Term Name: | pirtobrutinib |
---|---|
Synonyms: | 5-amino-3-{4-[(5-fluoro-2-methoxybenzamido)methyl]phenyl}-1-[(2S)-1,1,1-trifluoropropan-2-yl]-1H-pyrazole-4-carboxamide, Jaypirca, LOXO 305, LOXO-305, LY 3527727, LY-3527727, LY3527727, pirtobrutinib, pirtobrutinibum, RXC-005, RXC005 |
Definition: | A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-fluoro-2-methoxybenzoic acid with the amino group of 5-amino-3-[4-(aminomethyl)phenyl]-1-[(2S)-1,1,1-trifluoropropan-2-yl]-1H-pyrazole-4-carboxamide. It is a BTK inhibitor used for the treatment of adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. |
Ontology: | ChEBI [CHEBI:229212] ( EBI ) |